Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.

Martini A, Jia R, Ferket BS, Waingankar N, Plimack ER, Crabb SJ, Harshman LC, Yu EY, Powles T, Rosenberg JE, Pal SK, Vaishampayan UN, Necchi A, Wiklund NP, Mehrazin R, Mazumdar M, Sfakianos JP, Galsky MD.

Cancer. 2019 May 31. doi: 10.1002/cncr.32169. [Epub ahead of print]

PMID:
31150110
2.

Current role of robotic bladder cancer surgery.

Tyritzis SI, Gaya JM, Wallestedt-Lantz A, Pini G, Everaerts W, de Naeyer G, Palou J, Kelly J, Wiklund NP.

Minerva Urol Nefrol. 2019 May 7. doi: 10.23736/S0393-2249.19.03435-0. [Epub ahead of print]

PMID:
31086134
3.

A transcriptomic signature of tertiary Gleason 5 predicts worse clinicopathological outcome.

Martini A, Wang J, Brown NM, Cumarasamy S, Sfakianos JP, Rastinehad AR, Haines KG 3rd, Wiklund NP, Nair SS, Tewari AK.

BJU Int. 2019 Jul;124(1):155-162. doi: 10.1111/bju.14740. Epub 2019 Apr 3.

PMID:
30825357
4.

Robot-assisted extended lymphadenectomy in prostate cancer.

Tyritzis SI, Kalampokis N, Grivas N, van der Poel H, Wiklund NP.

Minerva Chir. 2019 Feb;74(1):88-96. doi: 10.23736/S0026-4733.18.07780-5. Epub 2018 Jul 23.

PMID:
30037178
5.

Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer.

Thiel T, Ryk C, Renström-Koskela L, Steineck G, Schumacher MC, Wiklund NP, de Verdier PJ.

World J Urol. 2019 Jan;37(1):155-163. doi: 10.1007/s00345-018-2375-7. Epub 2018 Jun 15.

6.

The current status of robot-assisted cystectomy.

Tyritzis SI, Collins JW, Wiklund NP.

Indian J Urol. 2018 Apr-Jun;34(2):101-109. doi: 10.4103/iju.IJU_355_17. Review.

7.

Is the open cystectomy era over? An update on the available evidence.

Tyritzis SI, Wiklund NP.

Int J Urol. 2018 Mar;25(3):187-195. doi: 10.1111/iju.13497. Epub 2017 Nov 26. Review.

8.

Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational Study.

Rajan P, Sooriakumaran P, Nyberg T, Akre O, Carlsson S, Egevad L, Steineck G, Wiklund NP.

J Clin Oncol. 2017 Nov 1;35(31):3566-3574. doi: 10.1200/JCO.2016.70.7794. Epub 2017 Sep 20.

9.

Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.

Rajan P, Hagman A, Sooriakumaran P, Nyberg T, Wallerstedt A, Adding C, Akre O, Carlsson S, Hosseini A, Olsson M, Egevad L, Wiklund F, Steineck G, Wiklund NP.

Eur Urol Focus. 2018 Apr;4(3):351-359. doi: 10.1016/j.euf.2016.10.007. Epub 2016 Nov 2.

PMID:
28753802
10.

Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy.

Sooriakumaran P, Nyberg T, Akre O, Widmark A, Hamdy F, Graefen M, Carlsson S, Steineck G, Wiklund NP.

Eur Urol. 2017 Sep;72(3):345-351. doi: 10.1016/j.eururo.2017.04.002. Epub 2017 Apr 14.

PMID:
28416350
11.

Prostaglandin D2 effects and DP1 /DP2 receptor distribution in guinea pig urinary bladder out-flow region.

Guan NN, Svennersten K, de Verdier PJ, Wiklund NP, Gustafsson LE.

J Cell Mol Med. 2017 Feb;21(2):234-243. doi: 10.1111/jcmm.12959. Epub 2016 Sep 23.

12.

Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.

Ryk C, Koskela LR, Thiel T, Wiklund NP, Steineck G, Schumacher MC, de Verdier PJ.

Redox Biol. 2015 Dec;6:272-277. doi: 10.1016/j.redox.2015.08.008. Epub 2015 Aug 10.

13.

Localization of P2X receptor subtypes 2, 3 and 7 in human urinary bladder.

Svennersten K, Hallén-Grufman K, de Verdier PJ, Wiklund NP, Poljakovic M.

BMC Urol. 2015 Aug 8;15:81. doi: 10.1186/s12894-015-0075-9.

14.

Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2.

Guan NN, Svennersten K, de Verdier PJ, Wiklund NP, Gustafsson LE.

Br J Pharmacol. 2015 Aug;172(16):4024-37. doi: 10.1111/bph.13174. Epub 2015 Jun 26.

15.

Enhanced recovery protocols (ERP) in robotic cystectomy surgery. Review of current status and trends.

Adding C, Collins JW, Laurin O, Hosseini A, Wiklund NP.

Curr Urol Rep. 2015 May;16(5):32. doi: 10.1007/s11934-015-0497-7. Review.

PMID:
25850413
16.

Robot-assisted radical cystectomy: extracorporeal vs intracorporeal urinary diversion.

Chan KG, Collins JW, Wiklund NP.

J Urol. 2015 May;193(5):1467-9. doi: 10.1016/j.juro.2015.02.042. Epub 2015 Feb 14. No abstract available.

PMID:
25686541
17.

Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open radical prostatectomy.

Wallerstedt A, Tyritzis SI, Thorsteinsdottir T, Carlsson S, Stranne J, Gustafsson O, Hugosson J, Bjartell A, Wilderäng U, Wiklund NP, Steineck G, Haglind E; LAPPRO steering committee.

Eur Urol. 2015 Apr;67(4):660-70. doi: 10.1016/j.eururo.2014.09.036. Epub 2014 Oct 11.

PMID:
25308968
18.

Tips and tricks for intracorporeal robot-assisted urinary diversion.

Collins JW, Hosseini A, Sooriakumaran P, Nyberg T, Sanchez-Salas R, Adding C, Schumacher MC, Wiklund NP.

Curr Urol Rep. 2014 Nov;15(11):457. doi: 10.1007/s11934-014-0457-7.

PMID:
25234190
19.

Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection.

Tyritzis SI, Wallerstedt A, Steineck G, Nyberg T, Hugosson J, Bjartell A, Wilderäng U, Thorsteinsdottir T, Carlsson S, Stranne J, Haglind E, Wiklund NP; LAPPRO Steering Committee.

J Urol. 2015 Jan;193(1):117-25. doi: 10.1016/j.juro.2014.08.091. Epub 2014 Aug 23.

PMID:
25158271
20.

Ureteral strictures revisited…trying to see the light at the end of the tunnel: a comprehensive review.

Tyritzis SI, Wiklund NP.

J Endourol. 2015 Feb;29(2):124-36. doi: 10.1089/end.2014.0522. Epub 2014 Oct 23. Review.

PMID:
25100183
21.

Robot-assisted radical cystectomy with intracorporeal neobladder diversion: The Karolinska experience.

Collins JW, Sooriakumaran P, Sanchez-Salas R, Ahonen R, Nyberg T, Wiklund NP, Hosseini A.

Indian J Urol. 2014 Jul;30(3):307-13. doi: 10.4103/0970-1591.134251.

22.

Cascade bioassay evidence for the existence of urothelium-derived inhibitory factor in Guinea pig urinary bladder.

Guan NN, Thor A, Hallén K, Wiklund NP, Gustafsson LE.

PLoS One. 2014 Aug 1;9(8):e103932. doi: 10.1371/journal.pone.0103932. eCollection 2014.

23.

Secondary stimulation from Bacillus Calmette-Guérin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells.

Thiel T, Ryk C, Chatzakos V, Hallén Grufman K, Bavand-Chobot N, Flygare J, Wiklund NP, de Verdier PJ.

Cancer Lett. 2014 Jun 28;348(1-2):119-25. doi: 10.1016/j.canlet.2014.03.014. Epub 2014 Mar 18.

PMID:
24657658
24.

The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.

Ryk C, Hou SM, Pershagen G, Wiklund NP, Nyberg F, de Verdier PJ.

Tumour Biol. 2014 May;35(5):4425-34. doi: 10.1007/s13277-013-1582-5. Epub 2014 Jan 10.

PMID:
24408018
25.

Totally intracorporeal robot-assisted radical cystectomy: optimizing total outcomes.

Collins JW, Wiklund NP.

BJU Int. 2014 Sep;114(3):326-33. doi: 10.1111/bju.12558. Epub 2014 Mar 5. Review.

26.

Launching and evolving a robotic cystectomy service by developing your 'FORTE'.

Collins JW, Sooriakumaran P, Wiklund NP.

BJU Int. 2014 Apr;113(4):520-2. doi: 10.1111/bju.12528. No abstract available.

27.

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.

Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, Ryk C, Wiklund NP, Steineck G, Schadendorf D, Hemminki K, Kumar R.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17426-31. doi: 10.1073/pnas.1310522110. Epub 2013 Oct 7.

28.

Prognostic significance of histopathological features of extraprostatic extension of prostate cancer.

Danneman D, Wiklund F, Wiklund NP, Egevad L.

Histopathology. 2013 Oct;63(4):580-9. doi: 10.1111/his.12199. Epub 2013 Jul 26.

PMID:
23889260
29.

Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy.

Collins JW, Tyritzis S, Nyberg T, Schumacher M, Laurin O, Khazaeli D, Adding C, Jonsson MN, Hosseini A, Wiklund NP.

Eur Urol. 2013 Oct;64(4):654-63. doi: 10.1016/j.eururo.2013.05.020. Epub 2013 May 27.

PMID:
23769588
30.

Oncologic, functional, and complications outcomes of robot-assisted radical cystectomy with totally intracorporeal neobladder diversion.

Tyritzis SI, Hosseini A, Collins J, Nyberg T, Jonsson MN, Laurin O, Khazaeli D, Adding C, Schumacher M, Wiklund NP.

Eur Urol. 2013 Nov;64(5):734-41. doi: 10.1016/j.eururo.2013.05.050. Epub 2013 Jun 6.

PMID:
23768634
31.

Nutritional status, gender and marital status in patients with chronic obstructive pulmonary disease.

Odencrants S, Bjuström T, Wiklund N, Blomberg K.

J Clin Nurs. 2013 Oct;22(19-20):2822-9. doi: 10.1111/jocn.12222. Epub 2013 May 16.

PMID:
23675677
32.

Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.

Seipel AH, Wiklund F, Wiklund NP, Egevad L.

Virchows Arch. 2013 Apr;462(4):429-36. doi: 10.1007/s00428-013-1385-5. Epub 2013 Feb 27.

PMID:
23443941
33.

Radical prostatectomy, sparing of the seminal vesicles, and painful orgasm.

Mogorovich A, Nilsson AE, Tyritzis SI, Carlsson S, Jonsson M, Haendler L, Nyberg T, Steineck G, Wiklund NP.

J Sex Med. 2013 May;10(5):1417-23. doi: 10.1111/jsm.12086. Epub 2013 Feb 19.

PMID:
23421911
34.

A totally intracorporeal approach will improve patient choice.

Collins JW, Wiklund NP.

Eur Urol. 2013 Apr;63(4):644-5. doi: 10.1016/j.eururo.2012.12.019. Epub 2012 Dec 20. No abstract available.

PMID:
23295107
35.

Patient and tumour-related factors for prediction of urinary incontinence after radical prostatectomy.

Wallerstedt A, Carlsson S, Steineck G, Thorsteinsdottir T, Hugosson J, Stranne J, Wilderäng U, Haglind E, Wiklund NP.

Scand J Urol. 2013 Aug;47(4):272-81. doi: 10.3109/00365599.2012.733410. Epub 2012 Nov 9.

PMID:
23137132
36.

Robot-assisted intracorporeal formation of the ileal neobladder.

Tyritzis SI, Hosseini A, Jonsson M, Adding C, Nilsson A, Wiklund NP.

J Endourol. 2012 Dec;26(12):1570-5. doi: 10.1089/end.2012.0424. Epub 2012 Nov 7.

PMID:
23134118
37.

Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer.

Koskela LR, Poljakovic M, Ehrén I, Wiklund NP, de Verdier PJ.

Nitric Oxide. 2012 Oct 15;27(3):185-91. doi: 10.1016/j.niox.2012.07.001. Epub 2012 Jul 20.

PMID:
22819699
38.

Radical surgery for treatment of primary localized bladder amyloidosis: could prostate-sparing robot-assisted cystectomy with intracorporeal urinary diversion be an option?

Hosseini A, Ploumidis A, Adding C, Wiklund NP.

Scand J Urol. 2013 Feb;47(1):72-5. doi: 10.3109/00365599.2012.693539. Epub 2012 Jul 2.

PMID:
22746326
39.

Robotic-assisted laparoscopic vesiculectomy for lower urinary tract obstruction by a large seminal vesicle cyst.

Ploumidis A, Sooriakumaran P, Philippou P, Wiklund NP.

Int J Surg Case Rep. 2012;3(8):375-8. doi: 10.1016/j.ijscr.2012.04.014. Epub 2012 May 1.

40.

Pad use and patient reported bother from urinary leakage after radical prostatectomy.

Wallerstedt A, Carlsson S, Nilsson AE, Johansson E, Nyberg T, Steineck G, Wiklund NP.

J Urol. 2012 Jan;187(1):196-200. doi: 10.1016/j.juro.2011.09.030. Epub 2011 Nov 17.

PMID:
22099992
41.

Robotic cystectomy: surgical technique.

Hosseini A, Adding C, Nilsson A, Jonsson MN, Wiklund NP.

BJU Int. 2011 Sep;108(6 Pt 2):962-8. doi: 10.1111/j.1464-410X.2011.10566.x.

42.

Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder.

Jonsson MN, Adding LC, Hosseini A, Schumacher MC, Volz D, Nilsson A, Carlsson S, Wiklund NP.

Eur Urol. 2011 Nov;60(5):1066-73. doi: 10.1016/j.eururo.2011.07.035. Epub 2011 Aug 4.

PMID:
21852033
43.

Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer.

Ryk C, Wiklund NP, Nyberg T, de Verdier PJ.

Nitric Oxide. 2011 Oct 30;25(3):338-43. doi: 10.1016/j.niox.2011.06.003. Epub 2011 Jun 13.

PMID:
21703358
44.

Orgasm-associated urinary incontinence and sexual life after radical prostatectomy.

Nilsson AE, Carlsson S, Johansson E, Jonsson MN, Adding C, Nyberg T, Steineck G, Wiklund NP.

J Sex Med. 2011 Sep;8(9):2632-9. doi: 10.1111/j.1743-6109.2011.02347.x. Epub 2011 Jun 23.

PMID:
21699660
45.

Ser608Leu polymorphisms in the nitric oxide synthase-2 gene may influence urinary bladder cancer pathogenesis.

Ryk C, Wiklund NP, Nyberg T, De Verdier PJ.

Scand J Urol Nephrol. 2011 Nov;45(5):319-25. doi: 10.3109/00365599.2011.584901. Epub 2011 May 25.

PMID:
21612325
46.

Age at surgery, educational level and long-term urinary incontinence after radical prostatectomy.

Nilsson AE, Schumacher MC, Johansson E, Carlsson S, Stranne J, Nyberg T, Wiklund NP, Steineck G.

BJU Int. 2011 Nov;108(10):1572-7. doi: 10.1111/j.1464-410X.2011.10231.x. Epub 2011 May 19.

47.

Robotic neobladder.

Wiklund NP, Poulakis V.

BJU Int. 2011 May;107(9):1514-37. doi: 10.1111/j.1464-410X.2011.10307.x. No abstract available.

48.

Recent advances in robot-assisted radical cystectomy.

Cha EK, Wiklund NP, Scherr DS.

Curr Opin Urol. 2011 Jan;21(1):65-70. Review.

PMID:
21171200
49.

ProMIS™ can serve as a da Vinci® simulator--a construct validity study.

Jonsson MN, Mahmood M, Askerud T, Hellborg H, Ramel S, Wiklund NP, Kjellman M, Ahlberg G.

J Endourol. 2011 Feb;25(2):345-50. doi: 10.1089/end.2010.0220. Epub 2010 Nov 29.

PMID:
21114413
50.

Defecation disturbances after cystectomy for urinary bladder cancer.

Thulin H, Kreicbergs U, Onelöv E, Ahlstrand C, Carringer M, Holmäng S, Ljungberg B, Malmström PU, Robinsson D, Wijkström H, Wiklund NP, Steineck G, Henningsohn L.

BJU Int. 2011 Jul;108(2):196-203. doi: 10.1111/j.1464-410X.2010.09815.x. Epub 2010 Nov 2.

Supplemental Content

Loading ...
Support Center